Black men are over-diagnosed with schizophrenia at least five times higher than any other group – a trend that dates back to the 1960s, according to new University of Michigan research.
Race-based misdiagnosis emerged in the context of the civil rights era of the 1960s and 1970s, when activism became equated with mental illness, says Jonathan [...]

Scientists have long eyed mutations in a gene known as DISC1 as a possible contributor to schizophrenia and mood disorders, including depression and bipolar disorder. Now, new research led by Johns Hopkins researchers suggests that perturbing this gene during prenatal periods, postnatal periods or both may have different effects in mice, leading to separate types [...]

The National Alliance on Mental Illness (NAMI) praises a new report, Caregiving in the U.S. 2009, which offers a revealing portrait of the nearly one-in-three American adults who serve as a family caregiver.

Intra-Cellular Therapies, Inc. (ITI) announced at a recent conference on neuropsychiatric diseases the results from a recently completed Phase I clinical study demonstrating ITI-007, the Company’s lead antipsychotic drug, interacts with important targets in the living human brain. These key targets are critical to drug action in many neuropsychiatric and related disorders. Using positron emission [...]

The 2009 American College of Neuropsychopharmacology Annual Meeting featured innovative research on PTSD, biomarkers for schizophrenia and treatment for gambling addiction. Study highlights included:

Researchers Use New Techniques to Assess PTSD. Working with Iraq and Afghanistan veterans, scientists have identified measurable traits that may be useful to evaluate PTSD and develop new treatments. Using blood [...]